Luke Nathaniel Walker Harpoon Therapeutics, Inc. (HARP) insider trading activity

Luke Nathaniel Walker is Chief Medical Officer of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2024, when has been sold 135,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Luke Nathaniel Walker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2024	SELL Sale (or disposition) back to the issuer	-	135,000 Reduced 100.0%	0 Common Stock
Jan 07 2024	BUY Grant, award, or other acquisition	-	115,000 Added 46.0%	135,000 Common Stock
Nov 26 2023	BUY Grant, award, or other acquisition	-	20,000 Added 50.0%	20,000 Common Stock

Also insider at

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

Director

CNTX

Context Therapeutics Inc. Healthcare

Director

LNW